+321 123 4567
info@test.com
My Account
  • Home
  • News
  • About
    • The ASCENT project
    • Digital Adherence Technologies
    • Our Approach
    • Funding & support
    • Consortium Partners
  • Countries
    • Ethiopia
    • South Africa
    • Tanzania
    • The Philippines
    • Ukraine
  • Technologies
    • Products
    • Market landscape
    • Market Size
    • Platform Workstream
  • Resources
  • Contact
  • connect with us

ASCENT Ethiopia presented DATs at the National Health Exhibition for six weeks

1 month ago
Ethiopia
No Comments

The national health exhibition organizing committee selected the ASCENT project for the National Health Exhibition to present Digital Adherence Technology.

Read More

Digital adherence technology scale-up in the Philippines revs up

6 months ago
The Phillippines
No Comments

Philippine Business for Social Progress (PBSP) is stepping up the training of 180 programmatic management of drug-resistant tuberculosis (PMDT) nurses and regional technical staff across the Philippines.

Read More

Technical brief: 5 Country Experiences with Digital Adherence Technologies

6 months ago
ASCENT
No Comments

Based on our experiences with implementing digital adherence technologies (DAT) at scale in five different contexts, we wrote a technical brief to highlight and summarize the ASCENT project implementation.

Read More

KNCV ramps up support for the expanded use of digital adherence technology in the Philippines

8 months ago
The Phillippines
No Comments

PBSP will expand the use of the smart pillbox for tuberculosis (TB) treatment in the Philippines. To jumpstart the scale-up, KNCV is providing technical support to PBSP.

Read More

Video: How Nugusse from Ethiopia got cured from tuberculosis using the smart pillbox

9 months ago
Ethiopia
No Comments

Nugusse, who rides horse drawn carriages for a living in Ethiopia, successfully completed his tuberculosis (TB) treatment using a digital adherence technology (DAT), provided by the ASCENT project.

Read More

Video: Tsedale from Ethiopia demonstrates the use of the medication label/sleeve for TB treatment

9 months ago
Ethiopia
No Comments

In this video, made in Ethiopia, Tsedale explains the advantages she experienced using a DAT, the medication sleeve/label, in comparison to DOT.

Read More

The smart pillbox carves a path to better tuberculosis management and cure

9 months ago
The Phillippines
No Comments

A first person account on how digital adherence technology can help reinforce medication adherence, in a way that benefits the patient and enhances health system efficiency.

Read More

ASCENT Philippines concludes digital adherence technology implementation activities; DAT scale-up assured in 2023

9 months ago
The Phillippines
No Comments

ASCENT concluded digital adherence technology (DAT) implementation activities in the Philippines. PBSP will expand DAT use nationwide.

Read More

Philippines scales up ASCENT’s implementation of digital technology for tuberculosis treatment

10 months ago
The Phillippines
No Comments

The ASCENT project will phase out in December 2022. The Philippines, however, will expand the use of digital adherence technology across the country in 2023.

Read More

Video: How a digital adherence technology, the medication sleeve/label, helps a small-scale farmer from Tanzania

10 months ago
Tanzania
No Comments

Meet Romana, a small scale farmer from Tanzania. She uses the medication sleeve/label to remind her to take her tuberculosis medication.

Read More

THE ASCENT PROJECT

The ASCENT project helps people affected with TB successfully complete their treatment through the use of digital adherence technologies and data-driven support interventions, utilizing smart pill boxes and other innovations. By generating evidence, establishing a global market and engaging stakeholders, ASCENT aims to make future scale up possible so that these digital innovations can be available to all TB patients worldwide.

Sign up to our newsletter

connect with us

Twitter
Facebook

This project is made possible thanks to
Unitaid funding and support.

Disclaimer – Privacy and Cookie statement

Subscribe to newsletter